The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, toric, multifocal, and specialty products designed to support different vision correction needs. Its CooperSurgical segment provides fertility, reproductive health, and women’s healthcare products and services, including medical devices, diagnostic tools, cryostorage solutions, and office-based surgical products. The Cooper Companies serves eye care professionals, fertility clinics, hospitals, and other healthcare providers across international markets. Headquartered in San Ramon, California, The Cooper Companies, Inc. plays an important role in specialized healthcare by combining consumer-facing vision products with clinical solutions for reproductive and women’s health.
No company news, with medical instrument and supply makers broadly higher as a group
| Series | 1W | 1M |
|---|---|---|
| COO | +8.4% | +14.2% |
| Peers | +4.9% | +12.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 74 | 72 |
The company is reviewing strategic alternatives, which can include a sale or merger.
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q3 FY2026 | 1.13 | 1.15 | +1.83% | — |
| Q2 FY2026 | 1.11 | 1.21 | +9.30% | — |
| Q1 FY2026 | 1.04 | 1.10 | +5.74% | — |
| Q4 FY2025 | 1.12 | 1.15 | +2.28% | — |
| Series | 1W | 1M |
|---|---|---|
| COO | +8.4% | +14.2% |
| Peers | +4.9% | +12.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 74 | 72 |